How to encourage investment in new drug therapies for diseases such as malaria and TB that afflict millions of individuals who live in countries with limited health care resources.

Why is R&D Process for New Drugs so Long and Costly?

"The ODA has been very successful --more than 200 drugs and biological products for rare diseases have been brought to the market since 1983.

In contrast, the decade prior to 1983 saw fewer than 10 such products come to the market."

· Could provide powerful stimulus to firms with established blockbuster products in U.S.

April97

http://www.healthsystem.virginia.edu/internet/pediatrics/pharma-news/April97.PDF

vitamin, infants, supplementation, mineral supplementation, Pediatr, adolescents, Pharmacotherapy, iron, nutrition, breast-fed infants, healthy.

Vitamin and Mineral Supplement Requirements of Healthy Children in the United States Clara Jane Snipes, R. Ph.

A growing public awareness of the role of vitamins and minerals in human nutrition is fostered by a combination of advertising pressure and concern about dietary adequacy.

Many people regard vitamin and mineral supplementation as a reliable method of ensuring dietary shortcomings are corrected.

Iron is the only mineral supplement commonly used.

The healthy, breast-fed, term infant of the well-nourished mother has not been shown conclusively to require any vitamin or mineral supplementation, provided the infant has adequate exposure to sunlight.

The author and editors of Pediatric Pharmacotherapy wish to thank Dr. Stephen Borowitz for his assistance in reviewing this article.

b984id.pdf

http://www.cignamedicare.com/partb/PDF/bltns/pastmb/1998/b984id.pdf

Medicare, physicians, providers, bills, codes, billing, carrier, healthcare, patients, care, payment.

A recent focused medical review of office consultation services (99241 - 99245) has revealed incorrect billing practices.

As of January 1, 1998, all Clinical Laboratory Improvement Amendment (CLIA) laboratory service claims submitted without a valid CLIA number are rejected as unprocessable.

Using the level of visit appropriate, the physician can bill Medicare for the covered portion of the visit, as if it had been done alone; The limiting charge rules apply to this covered portion of the visit on a nonassigned claim; The physician may bill the beneficiary for the Medicare noncovered portion of the visit, the amount by which the physician's current established charge for the entire visit exceeds his/her current established charge for the Medicare covered portion of the visit; and For example: A physician normally charges $150.00 for a routine physical examination and $50.00 of that amount represents the medically necessary (Medicare covered) portion.

mi-wi-HONC010.pdf

leukemia, lymphoma, cancer, chemotherapeutic agents, United Government Services, Medicare, drug, codes, policy, coverage, LLC.

This section prohibits Medicare payment for any claim which lacks the necessary information to process the claim.

This policy descibes a variety of chemotherapeutic agents and the conditions under which they are covered, including the diseases (and associated ICD-9CM codes) for which they are covered.

A. Coverage for medication is based on the patient's condition, the appropriateness of the dose and route of administration, based on the clinical condition and the standard of medical practice regarding the effectiveness of the drug for the diagnosis and condition.

B. The following well-established drugs will be allowed for cancer therapy and for other therapy as indicated.